Gyeonggi-do, South Korea

Jung-Hwa Kim



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jung-Hwa Kim in Pharmaceutical Formulations

Introduction

Jung-Hwa Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications that enhance stability and efficacy.

Latest Patents

Jung-Hwa Kim holds two patents, with his latest invention focusing on a pharmaceutical composition that includes clomipramine and sildenafil. This formulation aims to improve the stability of clomipramine, a medication commonly used for treating various mental health conditions. The invention details a method for manufacturing this pharmaceutical formulation using a wet granulation method, ensuring that both active ingredients are effectively combined to enhance their therapeutic properties.

Career Highlights

Jung-Hwa Kim is associated with Ctc Bio, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing formulations that address specific medical needs, thereby contributing to advancements in healthcare.

Collaborations

Jung-Hwa Kim collaborates with talented individuals in his field, including Hong Ryeol Jeon and Bong-Sang Lee. These partnerships foster a creative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Jung-Hwa Kim's contributions to pharmaceutical formulations demonstrate his dedication to improving medication stability and efficacy. His innovative work continues to impact the healthcare industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…